Literature DB >> 31285322

Nbn-Mre11 interaction is required for tumor suppression and genomic integrity.

Jun Hyun Kim1, Alexander V Penson2,3, Barry S Taylor2,3,4, John H J Petrini5.   

Abstract

We derived a mouse model in which a mutant form of Nbn/Nbs1mid8 (hereafter Nbnmid8) exhibits severely impaired binding to the Mre11-Rad50 core of the Mre11 complex. The Nbn mid8 allele was expressed exclusively in hematopoietic lineages (in Nbn -/mid8vav mice). Unlike Nbn flox/floxvav mice with Nbn deficiency in the bone marrow, Nbn -/mid8vav mice were viable. Nbn -/mid8vav mice hematopoiesis was profoundly defective, exhibiting reduced cellularity of thymus and bone marrow, and stage-specific blockage of B cell development. Within 6 mo, Nbn -/mid8 mice developed highly penetrant T cell leukemias. Nbn -/mid8vav leukemias recapitulated mutational features of human T cell acute lymphoblastic leukemia (T-ALL), containing mutations in NOTCH1, TP53, BCL6, BCOR, and IKZF1, suggesting that Nbn mid8 mice may provide a venue to examine the relationship between the Mre11 complex and oncogene activation in the hematopoietic compartment. Genomic analysis of Nbn -/mid8vav malignancies showed focal amplification of 9qA2, causing overexpression of MRE11 and CHK1 We propose that overexpression of MRE11 compensates for the metastable Mre11-Nbnmid8 interaction, and that selective pressure for overexpression reflects the essential role of Nbn in promoting assembly and activity of the Mre11 complex.

Entities:  

Keywords:  DNA damage response; Nbn−Mre11 interaction; genomic instability; tumor suppression

Year:  2019        PMID: 31285322      PMCID: PMC6660787          DOI: 10.1073/pnas.1905305116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  54 in total

1.  Mre11 complex and DNA replication: linkage to E2F and sites of DNA synthesis.

Authors:  R S Maser; O K Mirzoeva; J Wells; H Olivares; B R Williams; R A Zinkel; P J Farnham; J H Petrini
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

2.  Oligomerization is required for p53 to be efficiently ubiquitinated by MDM2.

Authors:  C G Maki
Journal:  J Biol Chem       Date:  1999-06-04       Impact factor: 5.157

3.  Checkpoint failure and chromosomal instability without lymphomagenesis in Mre11(ATLD1/ATLD1) mice.

Authors:  Jan-Willem F Theunissen; Mark I Kaplan; Patricia A Hunt; Bret R Williams; David O Ferguson; Frederick W Alt; John H J Petrini
Journal:  Mol Cell       Date:  2003-12       Impact factor: 17.970

4.  DNA replication-dependent nuclear dynamics of the Mre11 complex.

Authors:  Olga K Mirzoeva; John H J Petrini
Journal:  Mol Cancer Res       Date:  2003-01       Impact factor: 5.852

5.  NBS1 localizes to gamma-H2AX foci through interaction with the FHA/BRCT domain.

Authors:  Junya Kobayashi; Hiroshi Tauchi; Shuichi Sakamoto; Asako Nakamura; Ken-ichi Morishima; Shinya Matsuura; Toshiko Kobayashi; Katsuyuki Tamai; Keiji Tanimoto; Kenshi Komatsu
Journal:  Curr Biol       Date:  2002-10-29       Impact factor: 10.834

6.  The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder.

Authors:  G S Stewart; R S Maser; T Stankovic; D A Bressan; M I Kaplan; N G Jaspers; A Raams; P J Byrd; J H Petrini; A M Taylor
Journal:  Cell       Date:  1999-12-10       Impact factor: 41.582

7.  A murine model of Nijmegen breakage syndrome.

Authors:  Bret R Williams; Olga K Mirzoeva; William F Morgan; Junyu Lin; Wesley Dunnick; John H J Petrini
Journal:  Curr Biol       Date:  2002-04-16       Impact factor: 10.834

8.  Tumour p53 mutations exhibit promoter selective dominance over wild type p53.

Authors:  Paola Monti; Paola Campomenosi; Yari Ciribilli; Raffaella Iannone; Alberto Inga; Angelo Abbondandolo; Michael A Resnick; Gilberto Fronza
Journal:  Oncogene       Date:  2002-03-07       Impact factor: 9.867

9.  The Mre11 complex is required for repair of hairpin-capped double-strand breaks and prevention of chromosome rearrangements.

Authors:  Kirill S Lobachev; Dmitry A Gordenin; Michael A Resnick
Journal:  Cell       Date:  2002-01-25       Impact factor: 41.582

10.  Alternative translocation breakpoint cluster region 5' to BCL-6 in B-cell non-Hodgkin's lymphoma.

Authors:  Marion P Butler; Shinsuke Iida; Daniela Capello; Davide Rossi; Pulivarthi H Rao; Palanisamy Nallasivam; Diane C Louie; Seeta Chaganti; Thomas Au; Randy D Gascoyne; Gianluca Gaidano; Raju S K Chaganti; Riccardo Dalla-Favera
Journal:  Cancer Res       Date:  2002-07-15       Impact factor: 12.701

View more
  5 in total

Review 1.  Advances in synthetic lethality for cancer therapy: cellular mechanism and clinical translation.

Authors:  Win Topatana; Sarun Juengpanich; Shijie Li; Jiasheng Cao; Jiahao Hu; Jiyoung Lee; Kenneth Suliyanto; Diana Ma; Bin Zhang; Mingyu Chen; Xiujun Cai
Journal:  J Hematol Oncol       Date:  2020-09-03       Impact factor: 17.388

Review 2.  DNA Damage and Activation of cGAS/STING Pathway Induce Tumor Microenvironment Remodeling.

Authors:  Rong Shen; Disheng Liu; Xiaoning Wang; Zhao Guo; Haonan Sun; Yanfeng Song; Degui Wang
Journal:  Front Cell Dev Biol       Date:  2022-02-21

3.  ISG15 conjugation to proteins on nascent DNA mitigates DNA replication stress.

Authors:  Christopher P Wardlaw; John H J Petrini
Journal:  Nat Commun       Date:  2022-10-10       Impact factor: 17.694

4.  A gene dosage-dependent effect unveils NBS1 as both a haploinsufficient tumour suppressor and an essential gene for SHH-medulloblastoma.

Authors:  Marialaura Petroni; Francesca Fabretti; Stefano Di Giulio; Vittoria Nicolis di Robilant; Veronica La Monica; Marta Moretti; Francesca Belardinilli; Francesca Bufalieri; Anna Coppa; Paola Paci; Alessandro Corsi; Enrico De Smaele; Sonia Coni; Gianluca Canettieri; Lucia Di Marcotullio; Zhao-Qi Wang; Giuseppe Giannini
Journal:  Neuropathol Appl Neurobiol       Date:  2022-08-10       Impact factor: 6.250

5.  Modeling cancer genomic data in yeast reveals selection against ATM function during tumorigenesis.

Authors:  Marcel Hohl; Aditya Mojumdar; Sarem Hailemariam; Vitaly Kuryavyi; Fiorella Ghisays; Kyle Sorenson; Matthew Chang; Barry S Taylor; Dinshaw J Patel; Peter M Burgers; Jennifer A Cobb; John H J Petrini
Journal:  PLoS Genet       Date:  2020-03-18       Impact factor: 5.917

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.